Dr. Simone Krebs, M.D

NPI: 1861898728
Total Payments
$2,893
2023 Payments
$2,893
Companies
1
Transactions
2
Medicare Patients
1,563
Medicare Billing
$158,005

Payment Breakdown by Category

Other$2,000 (69.1%)
Travel$892.65 (30.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $2,000 1 69.1%
Travel and Lodging $892.65 1 30.9%

Top Paying Companies

Company Total Records Latest Year
Telix Pharmaceuticals $2,893 2 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2023 $2,893 2 Telix Pharmaceuticals ($2,893)

All Payment Transactions

2 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/06/2023 Telix Pharmaceuticals ILLUCCIX (Drug), ILLUCCIX Honoraria Cash or cash equivalent $2,000.00 General
Category: PROSTATE CANCER THERAPY
04/27/2023 Telix Pharmaceuticals ILLUCCIX (Drug) Travel and Lodging Cash or cash equivalent $892.65 General
Category: PROSTATE CANCER DIAGNOSIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 393 406 $254,010 $39,640
2022 3 387 393 $243,070 $37,617
2021 3 434 448 $277,550 $43,653
2020 2 349 359 $224,590 $37,096
Total Patients
1,563
Total Services
1,606
Medicare Billing
$158,005
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Facility 2023 343 354 $221,250 $34,542 15.6%
78816 Nuclear medicine study whole body with ct scan Facility 2023 50 52 $32,760 $5,098 15.6%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Facility 2022 339 344 $215,000 $33,438 15.6%
78816 Nuclear medicine study whole body with ct scan Facility 2022 35 35 $22,050 $3,378 15.3%
78608 Nuclear medicine study of brain with metabolic evaluation Facility 2022 13 14 $6,020 $800.31 13.3%
78815 Nuclear medicine study with ct imaging skull base to mid-thigh Facility 2021 364 378 $236,250 $37,132 15.7%
78816 Nuclear medicine study with ct imaging whole body Facility 2021 56 56 $35,280 $5,634 16.0%
78608 Nuclear medicine study brain with metabolic evaluation Facility 2021 14 14 $6,020 $887.04 14.7%
78815 Nuclear medicine study with ct imaging skull base to mid-thigh Facility 2020 306 316 $197,500 $32,648 16.5%
78816 Nuclear medicine study with ct imaging whole body Facility 2020 43 43 $27,090 $4,448 16.4%

About Dr. Simone Krebs, M.D

Dr. Simone Krebs, M.D is a Nuclear Medicine healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1861898728.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simone Krebs, M.D has received a total of $2,893 in payments from pharmaceutical and medical device companies, with $2,893 received in 2023. These payments were reported across 2 transactions from 1 company. The most common payment nature is "Honoraria" ($2,000).

As a Medicare-enrolled provider, Krebs has provided services to 1,563 Medicare beneficiaries, totaling 1,606 services with total Medicare billing of $158,005. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Nuclear Medicine
  • Location Houston, TX
  • Active Since 11/05/2014
  • Last Updated 11/12/2024
  • Taxonomy Code 207U00000X
  • Entity Type Individual
  • NPI Number 1861898728

Products in Payments

  • ILLUCCIX (Drug) $2,893

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nuclear Medicine Doctors in Houston